News
IGXT
0.170
+4.23%
0.007
Weekly Report: what happened at IGXT last week (0408-0412)?
Weekly Report · 16h ago
IntelGenx Trials Novel Parkinson’s Treatment
TipRanks · 04/08 12:07
Weekly Report: what happened at IGXT last week (0401-0405)?
Weekly Report · 04/08 12:05
INTELGENX ANNOUNCES FIRST PARKINSON’S DISEASE PATIENTS DOSED WITH MONTELUKAST VERSAFILM® IN PHASE 2 ‘MONTPARK’ CLINICAL TRIAL
Reuters · 04/08 11:45
Stocks in play: IntelGenx Corp.
Barchart · 04/08 08:42
IntelGenx Faces FDA Hurdle for Pain Management Drug
TipRanks · 04/05 12:38
INTELGENX: FDA CONFIRMED NO ADDITIONAL INSPECTION OF CO'S FACILITY IS REQUIRED AT THIS TIME
Reuters · 04/05 11:45
INTELGENX TECHNOLOGIES CORP: CRL INCLUDES A REQUEST FOR ADDITIONAL PHARMACEUTICAL QUALITY INFORMATION
Reuters · 04/05 11:45
Weekly Report: what happened at IGXT last week (0325-0329)?
Weekly Report · 04/01 12:02
Weekly Report: what happened at IGXT last week (0318-0322)?
Weekly Report · 03/25 12:06
IGXT Stock Earnings: Intelgenx Technologies Reported Results for Q4 2023
Intelgenx Technologies just reported results for the fourth quarter of 2023. The company reported earnings per share of -1 cent and revenue of $426,000. InvestorPlace Earnings is a project that automates coverage of quarterly earnings reports. Intelgenx technologies reported revenue of -3% for the quarter.
Investorplace · 03/21 17:53
IntelGenx Foresees Revenue Growth with RIZAFILM Launch
TipRanks · 03/21 12:07
IntelGenx GAAP EPS of -$0.01, revenue of $0.43M
IntelGenx Technologies Corp. Reports Q4 GAAP EPS of -$0.01, revenue of $0.43M. The company's cash and short-term investments totalled $2.3 million as of December 31, 2024. Q4 revenue was up 146.0% Y/Y.
Seeking Alpha · 03/21 11:49
*IntelGenx Technologies 4Q Loss/Shr $0.01 >IGX.T
Dow Jones · 03/21 11:33
*IntelGenx Technologies 4Q Loss $1.7M >IGX.T
Dow Jones · 03/21 11:33
*IntelGenx Technologies 4Q Rev $426,000 >IGX.T
Dow Jones · 03/21 11:32
Weekly Report: what happened at IGXT last week (0311-0315)?
Weekly Report · 03/18 12:03
IntelGenx Set to Unveil 2023 Financial Results
TipRanks · 03/14 21:07
IntelGenx to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 – Conference Call to Follow
Barchart · 03/14 15:30
IntelGenx Boosts Finances with Revised atai Agreement
TipRanks · 03/11 12:07
More
Webull provides a variety of real-time IGXT stock news. You can receive the latest news about Intelgenx Technologies Corp through multiple platforms. This information may help you make smarter investment decisions.
About IGXT
IntelGenx Technologies Corp is a Canada-based drug delivery company focused on the development of oral immediate-release and controlled-release products and on developing pharmaceutical products based on its drug delivery technologies. Its product development efforts are based upon over three delivery platform technologies, such as VersaFilm, an oral film technology; VersaTab, a multilayer tablet technology, and AdVersa, a mucoadhesive tablet technology. The VersaFilm technology consists of a thin (25 to 35 micron) polymeric film consisting of the United States Pharmacopeia (USP) components for use in food, pharmaceutical and cosmetic products. Its Multilayer Tablet platform technology allows for the development of oral controlled-release products. Its product portfolio includes INT0001/2004, INT0004/2006, INT0007/2006, INT0008/2007, INT0010/2006, INT0027/2011, INT0030/2011, INT0036/2013, INT0037/2013, INT0039/2013, INT0040/2014, INT0041/2015, INT0042/2015 and INT0043/2015.